Genetic Landscape in Women with Metastatic Ovarian Cancer Before and During Treatment with PARP Inhibitors

NCT06785077 · clinicaltrials.gov ↗

NA

Phase

RECRUITING

Status

157

Enrollment

OTHER

Sponsor class

Conditions

Leukemia, Myeloid, Acute
Myeloid Dysplasia
Ovarian Epithelial Cancer

Interventions

PROCEDURE: buccal cells
PROCEDURE: bone marrow cells
PROCEDURE: peripheral blood cells
PROCEDURE: bone marrow biopsy

Sponsor

European Institute of Oncology